易明醫藥(002826.SZ):擬定增募資不超2億-3.5億元 用於補充流動資金
格隆匯 4 月 6日丨易明醫藥(002826.SZ)披露2021年度非公開發行A股股票預案,擬非公開發行股票數量不低於2832.8612萬股(含本數)且不超過4957.507萬股(含本數),非公開發行股票數量上限未超過此次非公開發行前公司總股本的30%,全部以現金認購。依據公司與發行對象簽署的《附條件生效的股份認購協議》,發行對象認購情況如下:

此次非公開發行股票的價格為7.06元/股。公司此次非公開發行股票的定價基準日為公司第二屆董事會第十八次會議決議公吿日,發行價格不低於定價基準日前二十個交易日公司股票交易均價的百分之八十(定價基準日前二十個交易日股票交易均價=定價基準日前二十個交易日股票交易總額/定價基準日前二十個交易日股票交易總量)。
此次非公開發行A股股票計劃募集資金總額不低於2億元(含本數)且不超過3.5億元(含本數),扣除發行費用後的募集資金淨額將全部用於補充流動資金。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.